Concepts (216)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Capsaicin | 9 | 2023 | 28 | 2.370 |
Why?
|
| TRPV Cation Channels | 7 | 2022 | 24 | 1.850 |
Why?
|
| Neuromuscular Junction | 5 | 2019 | 35 | 1.600 |
Why?
|
| Guanylate Cyclase | 8 | 2013 | 21 | 1.140 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 6 | 2013 | 66 | 1.020 |
Why?
|
| Hydralazine | 1 | 2025 | 7 | 0.950 |
Why?
|
| Isosorbide Dinitrate | 1 | 2025 | 9 | 0.950 |
Why?
|
| Thermogenesis | 4 | 2021 | 26 | 0.940 |
Why?
|
| Glucosides | 1 | 2025 | 21 | 0.940 |
Why?
|
| Vasodilator Agents | 1 | 2025 | 55 | 0.930 |
Why?
|
| Obesity | 5 | 2023 | 1151 | 0.930 |
Why?
|
| Benzhydryl Compounds | 1 | 2025 | 50 | 0.910 |
Why?
|
| Adipose Tissue, White | 3 | 2021 | 18 | 0.810 |
Why?
|
| Heme | 3 | 2011 | 72 | 0.760 |
Why?
|
| Diabetic Neuropathies | 1 | 2022 | 12 | 0.760 |
Why?
|
| Nitric Oxide | 6 | 2025 | 386 | 0.730 |
Why?
|
| Heart Failure | 1 | 2025 | 302 | 0.720 |
Why?
|
| Diterpenes | 1 | 2022 | 97 | 0.720 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2022 | 131 | 0.670 |
Why?
|
| Adipose Tissue, Brown | 2 | 2021 | 46 | 0.650 |
Why?
|
| Gene Regulatory Networks | 1 | 2021 | 149 | 0.640 |
Why?
|
| Metabolism | 1 | 2019 | 9 | 0.610 |
Why?
|
| Mice | 14 | 2025 | 6644 | 0.600 |
Why?
|
| Animals | 24 | 2025 | 16992 | 0.590 |
Why?
|
| Lipolysis | 1 | 2017 | 20 | 0.530 |
Why?
|
| Spectrophotometry | 1 | 2017 | 63 | 0.530 |
Why?
|
| Energy Metabolism | 1 | 2018 | 187 | 0.530 |
Why?
|
| Glycerol | 1 | 2017 | 34 | 0.530 |
Why?
|
| Adipose Tissue | 2 | 2018 | 182 | 0.510 |
Why?
|
| Feeding Behavior | 2 | 2019 | 469 | 0.480 |
Why?
|
| Cholesterol | 1 | 2017 | 232 | 0.470 |
Why?
|
| Neuromuscular Agents | 1 | 2014 | 5 | 0.430 |
Why?
|
| Evoked Potentials, Motor | 1 | 2014 | 22 | 0.420 |
Why?
|
| TRPM Cation Channels | 3 | 2020 | 40 | 0.370 |
Why?
|
| Recombinant Proteins | 2 | 2013 | 518 | 0.370 |
Why?
|
| Muscle, Smooth, Vascular | 4 | 2013 | 140 | 0.360 |
Why?
|
| Receptors, Androgen | 3 | 2020 | 144 | 0.360 |
Why?
|
| Testosterone | 3 | 2020 | 211 | 0.350 |
Why?
|
| Aspartic Acid | 1 | 2011 | 51 | 0.340 |
Why?
|
| Acetylcholine | 4 | 2014 | 77 | 0.330 |
Why?
|
| Cyclophilin A | 3 | 2014 | 19 | 0.310 |
Why?
|
| Rats | 10 | 2022 | 3735 | 0.300 |
Why?
|
| Mice, Inbred C57BL | 6 | 2017 | 1869 | 0.290 |
Why?
|
| Cyclic GMP | 3 | 2025 | 53 | 0.280 |
Why?
|
| Mice, Knockout | 4 | 2019 | 1035 | 0.260 |
Why?
|
| Pain | 2 | 2022 | 290 | 0.250 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2025 | 20 | 0.240 |
Why?
|
| Disease Models, Animal | 3 | 2021 | 1596 | 0.230 |
Why?
|
| Drug Combinations | 1 | 2025 | 104 | 0.230 |
Why?
|
| Enzyme Activation | 5 | 2013 | 462 | 0.220 |
Why?
|
| Gene Expression Regulation | 2 | 2021 | 1070 | 0.220 |
Why?
|
| Stroke Volume | 1 | 2025 | 122 | 0.220 |
Why?
|
| COS Cells | 4 | 2013 | 68 | 0.220 |
Why?
|
| Oxidative Stress | 2 | 2025 | 1003 | 0.210 |
Why?
|
| Male | 10 | 2025 | 23409 | 0.210 |
Why?
|
| Angiotensin II | 3 | 2013 | 102 | 0.210 |
Why?
|
| Protein Structure, Tertiary | 4 | 2011 | 423 | 0.200 |
Why?
|
| Swine, Miniature | 1 | 2022 | 8 | 0.190 |
Why?
|
| Analgesics | 1 | 2022 | 55 | 0.180 |
Why?
|
| Swine | 1 | 2022 | 212 | 0.180 |
Why?
|
| Treatment Outcome | 1 | 2025 | 1604 | 0.170 |
Why?
|
| Type C Phospholipases | 1 | 2020 | 23 | 0.170 |
Why?
|
| Gene Knockdown Techniques | 1 | 2021 | 189 | 0.160 |
Why?
|
| Cells, Cultured | 5 | 2016 | 1621 | 0.160 |
Why?
|
| Sexual Behavior, Animal | 1 | 2020 | 64 | 0.160 |
Why?
|
| Mutation | 4 | 2013 | 1177 | 0.160 |
Why?
|
| Myocytes, Smooth Muscle | 4 | 2013 | 91 | 0.150 |
Why?
|
| Heart Function Tests | 1 | 2019 | 12 | 0.150 |
Why?
|
| Capsicum | 1 | 2018 | 4 | 0.150 |
Why?
|
| Organ Size | 1 | 2019 | 170 | 0.150 |
Why?
|
| Retrospective Studies | 1 | 2025 | 2544 | 0.140 |
Why?
|
| PPAR gamma | 1 | 2018 | 55 | 0.140 |
Why?
|
| Inflammation Mediators | 1 | 2019 | 140 | 0.140 |
Why?
|
| Diaphragm | 1 | 2017 | 11 | 0.130 |
Why?
|
| Behavior, Animal | 1 | 2020 | 373 | 0.130 |
Why?
|
| Body Weight | 1 | 2019 | 429 | 0.130 |
Why?
|
| Signal Transduction | 5 | 2020 | 2157 | 0.130 |
Why?
|
| Polyglycolic Acid | 1 | 2017 | 48 | 0.130 |
Why?
|
| Endocytosis | 1 | 2017 | 118 | 0.130 |
Why?
|
| Animals, Newborn | 1 | 2017 | 352 | 0.120 |
Why?
|
| Time Factors | 4 | 2014 | 1857 | 0.120 |
Why?
|
| Lactic Acid | 1 | 2017 | 112 | 0.120 |
Why?
|
| Protein Interaction Mapping | 2 | 2013 | 65 | 0.120 |
Why?
|
| Cytokines | 1 | 2019 | 678 | 0.110 |
Why?
|
| Vasodilation | 2 | 2012 | 64 | 0.110 |
Why?
|
| Humans | 10 | 2025 | 43102 | 0.110 |
Why?
|
| 4-Aminopyridine | 1 | 2014 | 8 | 0.110 |
Why?
|
| Ionomycin | 1 | 2014 | 11 | 0.110 |
Why?
|
| Potassium Channel Blockers | 1 | 2014 | 35 | 0.110 |
Why?
|
| Reflex | 1 | 2014 | 29 | 0.110 |
Why?
|
| Platelet Glycoprotein GPIIb-IIIa Complex | 1 | 2014 | 3 | 0.110 |
Why?
|
| Acetylcholinesterase | 1 | 2014 | 56 | 0.110 |
Why?
|
| Electromyography | 1 | 2014 | 69 | 0.100 |
Why?
|
| Mesenteric Arteries | 1 | 2014 | 20 | 0.100 |
Why?
|
| Electric Stimulation | 1 | 2014 | 186 | 0.100 |
Why?
|
| Female | 3 | 2025 | 24698 | 0.100 |
Why?
|
| Caveolae | 1 | 2013 | 10 | 0.100 |
Why?
|
| Half-Life | 1 | 2013 | 63 | 0.100 |
Why?
|
| Protein Subunits | 2 | 2011 | 93 | 0.100 |
Why?
|
| Protein Disulfide-Isomerases | 1 | 2013 | 12 | 0.100 |
Why?
|
| Blood Platelets | 1 | 2014 | 81 | 0.100 |
Why?
|
| Muscles | 1 | 2013 | 82 | 0.100 |
Why?
|
| Neuroblastoma | 1 | 2014 | 136 | 0.100 |
Why?
|
| Thrombosis | 1 | 2014 | 81 | 0.100 |
Why?
|
| Aorta | 2 | 2011 | 198 | 0.100 |
Why?
|
| Blotting, Western | 2 | 2013 | 883 | 0.100 |
Why?
|
| Aged | 1 | 2025 | 8214 | 0.100 |
Why?
|
| Models, Molecular | 3 | 2011 | 876 | 0.090 |
Why?
|
| Carbon Monoxide | 1 | 2011 | 47 | 0.090 |
Why?
|
| Catalytic Domain | 1 | 2011 | 118 | 0.090 |
Why?
|
| Alanine | 1 | 2011 | 34 | 0.090 |
Why?
|
| Indazoles | 1 | 2011 | 12 | 0.090 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2011 | 267 | 0.080 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2011 | 186 | 0.080 |
Why?
|
| Nostoc | 1 | 2010 | 1 | 0.080 |
Why?
|
| Benzoates | 1 | 2010 | 17 | 0.080 |
Why?
|
| Protein Binding | 4 | 2014 | 1082 | 0.080 |
Why?
|
| Molecular Mimicry | 1 | 2010 | 16 | 0.080 |
Why?
|
| Middle Aged | 1 | 2025 | 12222 | 0.080 |
Why?
|
| Reactive Oxygen Species | 4 | 2014 | 532 | 0.080 |
Why?
|
| Cell Line, Tumor | 2 | 2014 | 2676 | 0.080 |
Why?
|
| Immunoprecipitation | 3 | 2014 | 127 | 0.080 |
Why?
|
| Protein Kinases | 1 | 2007 | 100 | 0.070 |
Why?
|
| Nitrogen | 1 | 2007 | 84 | 0.060 |
Why?
|
| Acetylation | 2 | 2018 | 107 | 0.060 |
Why?
|
| Hypertension | 1 | 2012 | 835 | 0.060 |
Why?
|
| Immunohistochemistry | 2 | 2014 | 934 | 0.050 |
Why?
|
| Polymers | 1 | 2023 | 155 | 0.050 |
Why?
|
| Drug Delivery Systems | 1 | 2023 | 277 | 0.040 |
Why?
|
| Phosphatidylinositols | 1 | 2020 | 13 | 0.040 |
Why?
|
| Kainic Acid | 1 | 2020 | 48 | 0.040 |
Why?
|
| Ventral Tegmental Area | 1 | 2020 | 49 | 0.040 |
Why?
|
| Inflammation | 2 | 2017 | 758 | 0.040 |
Why?
|
| Cell Line | 2 | 2014 | 1410 | 0.040 |
Why?
|
| Aggression | 1 | 2020 | 102 | 0.040 |
Why?
|
| Cysteine | 2 | 2012 | 103 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2013 | 1124 | 0.040 |
Why?
|
| Transfection | 2 | 2012 | 532 | 0.040 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 2018 | 26 | 0.040 |
Why?
|
| Adipogenesis | 1 | 2018 | 14 | 0.040 |
Why?
|
| Social Behavior | 1 | 2020 | 161 | 0.040 |
Why?
|
| Mutagenesis | 2 | 2010 | 91 | 0.040 |
Why?
|
| Epididymis | 1 | 2018 | 29 | 0.040 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2018 | 28 | 0.040 |
Why?
|
| 3T3-L1 Cells | 1 | 2018 | 18 | 0.040 |
Why?
|
| Sirtuin 1 | 1 | 2018 | 34 | 0.040 |
Why?
|
| Ion Channel Gating | 1 | 2018 | 82 | 0.040 |
Why?
|
| PPAR alpha | 1 | 2018 | 42 | 0.040 |
Why?
|
| Crystallography, X-Ray | 2 | 2010 | 280 | 0.040 |
Why?
|
| Sex Characteristics | 1 | 2020 | 258 | 0.040 |
Why?
|
| Weight Loss | 1 | 2018 | 137 | 0.030 |
Why?
|
| Endothelial Cells | 2 | 2013 | 329 | 0.030 |
Why?
|
| Lipid Metabolism | 1 | 2018 | 148 | 0.030 |
Why?
|
| Fluorescein | 1 | 2017 | 18 | 0.030 |
Why?
|
| Solubility | 1 | 2017 | 139 | 0.030 |
Why?
|
| Delayed-Action Preparations | 1 | 2017 | 74 | 0.030 |
Why?
|
| Surface Properties | 1 | 2017 | 160 | 0.030 |
Why?
|
| Particle Size | 1 | 2017 | 272 | 0.030 |
Why?
|
| Fluorescent Dyes | 1 | 2017 | 182 | 0.030 |
Why?
|
| Drug Carriers | 1 | 2017 | 174 | 0.030 |
Why?
|
| Vagus Nerve Stimulation | 1 | 2014 | 2 | 0.030 |
Why?
|
| Transient Receptor Potential Channels | 1 | 2014 | 8 | 0.030 |
Why?
|
| Phrenic Nerve | 1 | 2014 | 18 | 0.030 |
Why?
|
| Exocytosis | 1 | 2014 | 49 | 0.030 |
Why?
|
| Lipid Bilayers | 1 | 2014 | 57 | 0.030 |
Why?
|
| Fibrinogen | 1 | 2014 | 24 | 0.030 |
Why?
|
| Platelet Aggregation | 1 | 2014 | 21 | 0.030 |
Why?
|
| Thrombin | 1 | 2014 | 28 | 0.030 |
Why?
|
| RNA, Messenger | 1 | 2018 | 1271 | 0.030 |
Why?
|
| Chlorides | 1 | 2014 | 59 | 0.030 |
Why?
|
| Hemorrhage | 1 | 2014 | 55 | 0.030 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2013 | 32 | 0.030 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2013 | 59 | 0.030 |
Why?
|
| Cell Survival | 1 | 2017 | 945 | 0.030 |
Why?
|
| Cytoskeleton | 1 | 2014 | 114 | 0.030 |
Why?
|
| Receptor, Angiotensin, Type 1 | 1 | 2013 | 30 | 0.030 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2013 | 41 | 0.030 |
Why?
|
| Ferric Compounds | 1 | 2014 | 62 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2014 | 458 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2013 | 196 | 0.020 |
Why?
|
| Cell Adhesion | 1 | 2014 | 238 | 0.020 |
Why?
|
| Oligopeptides | 1 | 2013 | 109 | 0.020 |
Why?
|
| Nitrosation | 1 | 2012 | 5 | 0.020 |
Why?
|
| Arterioles | 1 | 2012 | 19 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2013 | 256 | 0.020 |
Why?
|
| Protein Transport | 1 | 2013 | 296 | 0.020 |
Why?
|
| Vascular Resistance | 1 | 2012 | 36 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2013 | 296 | 0.020 |
Why?
|
| Nitric Oxide Donors | 1 | 2012 | 41 | 0.020 |
Why?
|
| Hela Cells | 1 | 2013 | 376 | 0.020 |
Why?
|
| Calcium | 1 | 2014 | 491 | 0.020 |
Why?
|
| Oxidation-Reduction | 1 | 2013 | 457 | 0.020 |
Why?
|
| Gene Expression | 1 | 2014 | 701 | 0.020 |
Why?
|
| Models, Animal | 1 | 2011 | 151 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2013 | 458 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2013 | 665 | 0.020 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2012 | 185 | 0.020 |
Why?
|
| Rats, Wistar | 1 | 2011 | 283 | 0.020 |
Why?
|
| Enzyme Activators | 1 | 2010 | 11 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2013 | 986 | 0.020 |
Why?
|
| Peptides | 1 | 2013 | 372 | 0.020 |
Why?
|
| Protein Structure, Secondary | 1 | 2010 | 182 | 0.020 |
Why?
|
| Blood Pressure | 1 | 2012 | 666 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 2010 | 506 | 0.020 |
Why?
|
| Haplorhini | 1 | 2007 | 23 | 0.020 |
Why?
|
| S-Nitrosothiols | 1 | 2007 | 4 | 0.020 |
Why?
|
| Veins | 1 | 2007 | 7 | 0.020 |
Why?
|
| Dimerization | 1 | 2007 | 112 | 0.020 |
Why?
|
| Conserved Sequence | 1 | 2007 | 122 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2012 | 1766 | 0.020 |
Why?
|
| Cell Separation | 1 | 2007 | 94 | 0.020 |
Why?
|
| Genome | 1 | 2007 | 149 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2007 | 183 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 2007 | 307 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2007 | 1180 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2007 | 1542 | 0.010 |
Why?
|